BridgeBio Pharma (BBIO) EPS (Basic) Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -13.31% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -100.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 61.11% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3,856.63% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -7.78% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,207.14% |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | 4.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.55% |
| Dec 31, 2025 | 30.28% |
| Sep 30, 2025 | -10.47% |
| Jun 30, 2025 | -143.59% |
| Mar 31, 2025 | -340.00% |
| Dec 31, 2024 | -47.92% |
| Sep 30, 2024 | 20.37% |
| Jun 30, 2024 | 60.20% |
| Mar 31, 2024 | 78.26% |
| Dec 31, 2023 | -4.35% |
| Sep 30, 2023 | -16.13% |
| Jun 30, 2023 | -1,300.00% |
| Mar 31, 2023 | 31.85% |
| Dec 31, 2022 | 9.80% |
| Sep 30, 2022 | 12.26% |
| Jun 30, 2022 | 89.39% |
| Mar 31, 2022 | -14.41% |
| Dec 31, 2021 | -0.99% |
| Sep 30, 2021 | -8.16% |
| Jun 30, 2021 | 35.92% |
| Mar 31, 2021 | -51.28% |
| Dec 31, 2020 | -62.90% |
| Sep 30, 2020 | -92.16% |
| Jun 30, 2020 | -45.07% |
| Mar 31, 2020 | -18.18% |
| Dec 31, 2019 | -19.23% |
| Sep 30, 2019 | 1.92% |
| Jun 30, 2019 | 58.48% |